Guangzhou Kingmed Diagnostics Group Co., Ltd. (603882.SS)
CNY 31.24
(-1.26%)
CNY 31.24
(-1.26%)
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2023 | 248.2 Million CNY | -38.75% |
| 2022 | 405.25 Million CNY | 17.42% |
| 2021 | 345.14 Million CNY | 44.94% |
| 2020 | 238.12 Million CNY | 38.84% |
| 2019 | 171.5 Million CNY | 34.43% |
| 2018 | 127.58 Million CNY | 35.38% |
| 2017 | 94.24 Million CNY | 16.26% |
| 2016 | 81.06 Million CNY | 20.53% |
| 2015 | 67.25 Million CNY | 31.42% |
| 2014 | 51.17 Million CNY | -17.01% |
| 2013 | 61.66 Million CNY | 56.64% |
| 2012 | 39.36 Million CNY | 0.0% |
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2024 Q3 | 219.72 Million CNY | -3.88% |
| 2024 Q1 | 239.98 Million CNY | -3.31% |
| 2024 Q2 | 228.6 Million CNY | -4.74% |
| 2023 Q4 | 248.2 Million CNY | -9.07% |
| 2023 FY | 248.2 Million CNY | -38.75% |
| 2023 Q1 | 294.71 Million CNY | -27.28% |
| 2023 Q2 | 268.55 Million CNY | -8.88% |
| 2023 Q3 | 272.97 Million CNY | 1.65% |
| 2022 Q3 | 390.37 Million CNY | 7.99% |
| 2022 Q2 | 361.47 Million CNY | -14.56% |
| 2022 Q1 | 423.06 Million CNY | 22.58% |
| 2022 FY | 405.25 Million CNY | 17.42% |
| 2022 Q4 | 405.25 Million CNY | 3.81% |
| 2021 Q1 | 307.62 Million CNY | 29.18% |
| 2021 Q3 | 328.98 Million CNY | 17.94% |
| 2021 Q4 | 345.14 Million CNY | 4.91% |
| 2021 FY | 345.14 Million CNY | 44.94% |
| 2021 Q2 | 278.94 Million CNY | -9.32% |
| 2020 Q4 | 238.12 Million CNY | 2.34% |
| 2020 FY | 238.12 Million CNY | 38.84% |
| 2020 Q1 | 171.6 Million CNY | 0.05% |
| 2020 Q2 | 200.82 Million CNY | 17.03% |
| 2020 Q3 | 232.68 Million CNY | 15.87% |
| 2019 FY | 171.5 Million CNY | 34.43% |
| 2019 Q4 | 171.5 Million CNY | -7.17% |
| 2019 Q3 | 184.75 Million CNY | 14.87% |
| 2019 Q2 | 160.83 Million CNY | 21.96% |
| 2019 Q1 | 131.86 Million CNY | 3.36% |
| 2018 Q1 | 92 Million CNY | -2.38% |
| 2018 Q2 | 130.15 Million CNY | 41.46% |
| 2018 FY | 127.58 Million CNY | 35.38% |
| 2018 Q3 | 143.41 Million CNY | 10.19% |
| 2018 Q4 | 127.58 Million CNY | -11.04% |
| 2017 Q3 | 111.96 Million CNY | 24.31% |
| 2017 Q1 | - CNY | -100.0% |
| 2017 FY | 94.24 Million CNY | 16.26% |
| 2017 Q2 | 90.06 Million CNY | 0.0% |
| 2017 Q4 | 94.24 Million CNY | -15.82% |
| 2016 Q4 | 81.06 Million CNY | 0.0% |
| 2016 FY | 81.06 Million CNY | 20.53% |
| 2015 Q3 | 62.46 Million CNY | 0.0% |
| 2015 FY | 67.25 Million CNY | 31.42% |
| 2015 Q4 | 67.25 Million CNY | 7.67% |
| 2014 FY | 51.17 Million CNY | -17.01% |
| 2013 FY | 61.66 Million CNY | 56.64% |
| 2012 FY | 39.36 Million CNY | 0.0% |
| Name | Inventory | Inventory Difference |
|---|---|---|
| Shanghai Runda Medical Technology Co., Ltd. | 1.37 Billion CNY | 81.974% |
| Joinn Laboratories(China)Co.,Ltd. | 1.86 Billion CNY | 86.678% |
| WuXi AppTec Co., Ltd. | 4.73 Billion CNY | 94.759% |
| Autobio Diagnostics Co., Ltd. | 778.28 Million CNY | 68.109% |
| Thalys Medical Technology Group Inc. | 341.6 Million CNY | 27.34% |
| Chemclin Diagnostics Co., Ltd. | 110.6 Million CNY | -124.408% |